Come up with a name for your new list and we'll add to it:
InVasc Therapeutics raised a round of funding on May 14, 2010. Investors include
National Institutes of Health.
InVasc Therapeutics specializes in target-specific drug discovery and has developed a approach to drug discovery that uses molecular structures and an application-based platform that decreases the ti…